1. Angus, DC, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 2001; 29: 1303–1310.
2. Dombrovskiy, VY, et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Critical Care Medicine 2007; 35: 1244–1250.
3. Harrison, DA, et al. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Critical Care 2006; 10: R42.
4. Vincent, JL, et al. Sepsis in European intensive care units: results of the SOAP study. Critical Care Medicine 2006; 34: 344–353.
5. Adrie, C, et al. Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. Journal of Critical Care 2005; 20: 46–58.
6. Annane, D, et al. Current epidemiology of septic shock: the CUB-Rea Network. American Journal of Respiratory and Critical Care Medicine 2003; 168: 165–172.
7. Alberti, C, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Medicine 2002; 28: 108–121.
8. Brun-Buisson, C, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. Journal of the American Medical Association 1995; 274: 968–974.
9. Brun-Buisson, C, et al. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Medicine 2004; 30: 580–588.
10. Cheng, B, et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Critical Care Medicine 2007; 35: 2538–2546.
11. Engel, C, et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Medicine 2007; 33: 606–618.
12. Finfer, S, et al. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Medicine 2004; 30: 589–596.
13. Karlsson, S, et al. Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study. Intensive Care Medicine 2007; 33: 435–443.
14. Silva, E, et al. Brazilian Sepsis Epidemiological Study (BASES study). Critical Care 2004; 8: R251–260.
15. Padkin, A, et al. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Critical Care Medicine 2003; 31: 2332–2338.
16. Tanriover, MD, et al. Epidemiology and outcome of sepsis in a tertiary-care hospital in a developing country. Epidemiology and Infection 2006; 134: 315–322.
17. Calandra, T, Cohen, J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Critical Care Medicine 2005; 33: 1538–1548.
18. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 1992; 20: 864–874.
19. Vincent, JL, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Medicine 1996; 22: 707–710.
20. Knaus, WA, et al. APACHE II: a severity of disease classification system. Critical Care Medicine 1985; 13: 818–829.
21. Le Gall, JR, et al. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. Journal of the American Medical Association 1996; 276: 802–810.
22. Finfer, S, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine 2004; 350: 2247–2256.
23. Alberti, C, et al. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. American Journal of Respiratory and Critical Care Medicine 2003; 168: 77–84.
24. Pittet, D, et al. Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. American Journal of Respiratory and Critical Care Medicine 1996; 153: 684–693.
25. Ferreira, FL, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. Journal of the American Medical Association 2001; 286: 1754–1758.
26. Khwannimit, B. A comparison of three organ dysfunction scores: MODS, SOFA and LOD for predicting ICU mortality in critically ill patients. Journal of the Medical Association of Thailand 2007; 90: 1074–1081.
27. Khwannimit, B, Geater, A. A comparison of APACHE II and SAPS II scoring systems in predicting hospital mortality in Thai adult intensive care units. Journal of the Medical Association of Thailand 2007; 90: 643–652.
28. Estenssoro, E, et al. Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome. Critical Care Medicine 2002; 30: 2450–2456.
29. Zilberberg, MD, Epstein, SK. Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome. American Journal of Respiratory and Critical Care Medicine 1998; 157: 1159–1164.
30. Yu, DT, et al. Relationship of pulmonary artery catheter use to mortality and resource utilization in patients with severe sepsis. Critical Care Medicine 2003; 31: 2734–2741.
31. Sandham, JD, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. New England Journal of Medicine 2003; 348: 5–14.
32. Wheeler, AP, et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. New England Journal of Medicine 2006; 354: 2213–2224.
33. Harvey, S, et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet 2005; 366: 472–477.